Medical device manufacturers will have a clearer picture of the post-Brexit system of medical device regulation in the UK once a number of focus groups, to be appointed by the Medicines and Healthcare products regulatory Agency (MHRA), can get down to developing key aspects of guidance that will accompany the new regulations.
The focus groups will base their work on the government’s response to the MHRA’s 2021 UK regulatory consultation. The new sovereign UK law will amend the current statutory instrument, the...